Asia's Outbreaks Risk Renewed Infection, Economic Stagnation

Investors should watch Asian vaccination rates for a guide to the continent's economic rebound.

A Healthy Outlook for Merck and Its Organon Spinoff

Organon's management team has deep leadership, operating and financial experience.

With Controversy Aplenty, Robinhood Goes Public

Is HOOD walking into the public spotlight with a bulls-eye on its back before it gets a chance to prove itself?

The Good, Weird and Ugly of Facebook

Their earnings were a blowout but it's too dangerous to short the name.

I'm Bottom Fishing and Nibbling Amid Positive Action

There just isn't much downside left in most of the small-caps that have already been hit hard.

Should U.S. Investors Ever Trust Chinese Stocks Again?

After being burned by Beijing, many U.S. investors are rightfully left wondering about their China-linked holdings.

What the Fed Said and Did, Robinhood IPO, Trading Ford, Facebook and ServiceNow

Are traders and investors confused? Possibly. Was that the intent? No, but I think Jerome Powell is fine with that.

Jim Cramer: To Crack the Code During Earnings Season, Follow the Boost

Here's what investors need to know to discern the direction of stocks during what can be a confusing season.

Traders Looking for More Rotational Action as Facebook Stumbles

Senior indices and many big-caps are technically extended and prone to 'sell the news' reactions.

Coffee Talk: Is This a Repeat of 2014 or 2011?

In a year full of boom and bust commodity moves, let's spill the beans on coffee's unruly rally.